272 related articles for article (PubMed ID: 28187879)
1. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
[TBL] [Abstract][Full Text] [Related]
2. A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection.
Jagadabi V; Nagendra Kumar PV; Mahesh K; Pamidi S; Ramaprasad LA; Nagaraju D
J Chromatogr Sci; 2019 Jan; 57(1):44-53. PubMed ID: 30169761
[TBL] [Abstract][Full Text] [Related]
3. Gradient HPLC-DAD stability indicating determination of miconazole nitrate and lidocaine hydrochloride in their combined oral gel dosage form.
Belal TS; Haggag RS
J Chromatogr Sci; 2012 May; 50(5):401-9. PubMed ID: 22407005
[TBL] [Abstract][Full Text] [Related]
4. RP-HPLC method development and validation for quantification of daclatasvir dihydrochloride and its application to pharmaceutical dosage form.
Hussain Shah SS; Nasiri MI; Sarwar H; Ali A; S Naqvi SB; Anwer S; Kashif M
Pak J Pharm Sci; 2021 May; 34(3):951-956. PubMed ID: 34602418
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating HPLC-DAD determination of ribavirin in capsules and plasma.
Haggag RS; Belal SF; Hewala II; El Rouby OA
J Chromatogr Sci; 2014 Jul; 52(6):493-500. PubMed ID: 23749878
[TBL] [Abstract][Full Text] [Related]
6. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2018 Jan; 76(1):16-31. PubMed ID: 28842163
[TBL] [Abstract][Full Text] [Related]
7. STABILITY-INDICATING HPLC METHOD FOR DETERMINATION OF VANCOMYCIN HYDROCHLORIDE IN THE PHARMACEUTICAL DOSAGE FORMS.
Serri A; Moghimp HR; Mahboubi A; Zarghi A
Acta Pol Pharm; 2017 Jan; 74(1):73-79. PubMed ID: 29474763
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of HPLC Fluorescence and UPLC/DAD Stability-Indicating Methods for Determination of Hepatitis C Antiviral Agent Daclatasvir.
Kamal AH; Ismail NS; Mabrouk MM; Bebawy LI; Mekky MA
J AOAC Int; 2019 Jul; 102(4):1125-1131. PubMed ID: 30940292
[No Abstract] [Full Text] [Related]
9. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
Baker MM; Hammad SF; Belal TS
Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
[TBL] [Abstract][Full Text] [Related]
10. Development and greenness assessment of a stability-indicating HPLC-DAD method for simultaneous determination of allopurinol and benzbromarone.
El-Kafrawy DS; Abdelhamid AG; Abdel-Khalek MM; Belal TS
Drug Dev Ind Pharm; 2021 Jun; 47(6):887-896. PubMed ID: 33899636
[TBL] [Abstract][Full Text] [Related]
11. Forced Degradation and Stability-Indicating Study for the Binary Mixture of Allopurinol and Thioctic Acid Using Validated HPLC-DAD Method.
El-Kafrawy DS; Abdelhamid AG; Abdel-Khalek MM; Belal TS
J AOAC Int; 2023 Jul; 106(4):854-865. PubMed ID: 36847424
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
Patel HU; Suhagia BN; Patel CN
J AOAC Int; 2010; 93(6):1862-7. PubMed ID: 21313813
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
14. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
[TBL] [Abstract][Full Text] [Related]
15. Analytical investigation of ternary mixture of phenylephrine hydrochloride, dimetindene maleate and benzalkonium chloride using validated stability indicating HPLC-DAD method.
Abdelhamid AG; El-Kafrawy DS; Abdel-Khalek MM; Belal TS
Drug Dev Ind Pharm; 2020 Aug; 46(8):1278-1288. PubMed ID: 32594780
[TBL] [Abstract][Full Text] [Related]
16. Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(4):749-63. PubMed ID: 26279975
[TBL] [Abstract][Full Text] [Related]
17. Validated Stability-Indicating HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Diflunisal in Their Combined Dosage Form.
Shaalan RA; Belal TS
Sci Pharm; 2013; 81(3):713-31. PubMed ID: 24106669
[TBL] [Abstract][Full Text] [Related]
18. Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(3):541-54. PubMed ID: 25853066
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
[TBL] [Abstract][Full Text] [Related]
20. Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC.
Satheeshkumar N; Pradeepkumar M; Shanthikumar S; Rao VJ
Drug Res (Stuttg); 2014 Mar; 64(3):124-9. PubMed ID: 24081820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
